FINWIRES · TerminalLIVE
FINWIRES

MannKind Says Phase 1b Study Shows Idiopathic Pulmonary Fibrosis Treatment Generally Safe, Well-Tolerated

By

MannKind's (MNKD) phase 1b study evaluating nintedanib dry powder inhalation in patients with idiopathic pulmonary fibrosis showed that the drug was generally safe and well-tolerated, meeting its primary endpoint, the company said Wednesday.

The study, which enrolled 27 patients across 10 US sites and assessed two multiple-ascending dose regimens, showed that 60% reported no cough and 30% reported mild cough, according to a statement.

There were no serious adverse events, no drug-related gastrointestinal side effects, and no treatment discontinuations or dose reductions, MannKind said.

The company said it is enrolling patients for the phase 2 trial, which is expected to have around 210 participants across 85 sites worldwide and is designed to further evaluate the safety, tolerability, and efficacy of the drug.

Price: $3.90, Change: $-0.01, Percent Change: -0.28%

Related Articles

Wire

Orion Q2 Adjusted Earnings Fall, Revenue Rises; Cuts 2026 EPS Guidance

Orion Group (ORN) reported Q2 adjusted earnings late Tuesday of $0.02 per share, down from $0.07 a year earlier.Analysts polled by FactSet expected $0.06.Revenue for the quarter ended June 30 rose to $221.9 million from $205.3 million a year earlier.Analysts expected $225.7 million.The company now expects 2026 adjusted EPS of $0.23 to $0.30, compared with $0.36 to $0.42 earlier. The company continues to see full-year revenue of $900 million to $950 million.Analysts expect $0.39 and $938.9 million, respectively.Shares of Orion were down 8% in after-hours activity.

$ORN
Wire

Rogers Q2 Adjusted Earnings, Revenue Rise

Rogers (ROG) reported Q2 adjusted earnings late Tuesday of $0.92 per diluted share, up from $0.34 a year earlier.Three analysts polled by FactSet expected $0.99.Revenue in the three months ended June 30 rose to $216.8 million from $202.8 million a year earlier.Three analysts surveyed by FactSet expected $215 million.The company expects Q3 adjusted EPS of $1.10 to $1.30 on revenue of $233 million to $243 million.Three analysts expect EPS of $1.03 on revenue of $225.5 million.The company's shares fell 2% in after-hours trading.

$ROG
Wire

Extra Space Storage Q2 Core FFO, Revenue Rise

Extra Space Storage (EXR) reported Q2 core funds from operations late Tuesday of $2.15 per diluted share, up from $2.05 a year earlier.Analysts polled by FactSet expected $2.07.Revenue for the three months ended June 30 rose to $874.2 million from $841.6 million a year earlier.Analysts expected $875 million.The company raised full-year core FFO guidance to $8.25 to $8.40 a share from the prior range of $8.05 to 8.35. Analysts expect $8.29.The company's shares fell 1.5% in after-hours trading.

$EXR